Women’s Core Heart & Metabolic Screening Panel
Comprehensive heart and metabolic screening for women. This advanced panel evaluates cholesterol, ApoB, Lipoprotein (a), inflammation (hs-CRP), blood sugar control, insulin, thyroid function, vitamin D, ferritin, and overall metabolic health. Designed to support proactive cardiovascular risk assessment and long-term metabolic wellness with clinically relevant biomarkers in one integrated blood test panel.
- $1,243.75
- $284.95
- Save: 77.09%
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Apolipoprotein B
Also known as: CBC, CBC includes Differential and Platelets, CBC/PLT w/DIFF, Complete Blood Count (includes Differential and Platelets)
NOTE: Ulta Lab Tests provides CBC test results from Quest Diagnostics as they are reported. Often, different biomarker results are made available at different time intervals. When reporting the results, Ulta Lab Tests denotes those biomarkers not yet reported as 'pending' for every biomarker the test might report. Only biomarkers Quest Diagnostics observes are incorporated and represented in the final CBC test results provided by Ulta Lab Tests.
Absolute Band Neutrophils (Only Reported If Detected)
Absolute Basophils
Absolute Blasts (Only Reported If Detected)
Absolute Eosinophils
Absolute Lymphocytes
Absolute Metamyelocytes (Only Reported If Detected)
Absolute Monocytes
Absolute Myelocytes (Only Reported If Detected)
Absolute Neutrophils
Absolute Nucleated Rbc (Only Reported If Detected)
Absolute Promyelocytes (Only Reported If Detected)
Band Neutrophils (Only Reported If Detected)
Basophils
Blasts (Only Reported If Detected)
Eosinophils
Hematocrit
Hemoglobin
Lymphocytes
MCH
MCHC
MCV
Metamyelocytes (Only Reported If Detected)
Monocytes
MPV
Myelocytes (Only Reported If Detected)
Neutrophils
Nucleated Rbc (Only Reported If Detected)
Platelet Count
Promyelocytes (Only Reported If Detected)
RDW
Reactive Lymphocytes (Only Reported If Detected)
Red Blood Cell Count
White Blood Cell Count
Also known as: Chem 12, Chemistry Panel, Chemistry Screen, CMP, Complete Metabolic Panel, Comprehensive Metabolic Panel CMP, SMA 12, SMA 20
Albumin
Albumin/Globulin Ratio
Alkaline Phosphatase
Alt
AST
Bilirubin, Total
Bun/Creatinine Ratio
Calcium
Carbon Dioxide
Chloride
Creatinine
Egfr African American
Egfr Non-Afr. American
GFR-AFRICAN AMERICAN
GFR-NON AFRICAN AMERICAN
Globulin
Glucose
Potassium
Protein, Total
Sodium
Urea Nitrogen (Bun)
Ferritin
Also known as: A1c, Glycated Hemoglobin, Glycohemoglobin, Glycosylated Hemoglobin, HA1c, HbA1c, Hemoglobin A1c, Hemoglobin A1c HgbA1C, Hgb A1c
HEMOGLOBIN A1C
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Hs Crp
Also known as: Insulin (fasting)
Insulin
Also known as: Cholesterol, HDL,Fasting Lipids,Cholesterol, LDL, Fasting Lipids, Lipid Panel (fasting), Lipid Profile (fasting), Lipids
Chol/HDLC Ratio
Cholesterol, Total
HDL Cholesterol
LDL-Cholesterol
Non HDL Cholesterol
Triglycerides
Also known as: Lipoprotein A, Lp (a), Lp(a)
Lipoprotein (A)
Also known as: Free T4, FT4, T4 Free
T4, Free
Also known as: Thyroid Stimulating Hormone Test, Thyrotropin Test
TSH
Also known as: ,25-Hydroxyvitamin D2, 25-Hydroxycholecalciferol (25OHD3), 25-OH-D2,D3 Vitamin, D2 Vitamin,25-Hydroxyvitamin D3,25-OH-D3, QuestAssureD 25Hydroxyvitamin D D2 D3 LCMSMS, Vitamin D, Vitamin D, 25-Hydroxy, Vitamin D2, 25-hydroxy,25-Hydroxyergocalciferol (25OHD2),Vitamin D3, 25-hydroxy
Vitamin D, 25-Oh, Total
The Women’s Core Heart & Metabolic Screening Panel panel contains 12 tests with 69 biomarkers .
A Comprehensive Cardiometabolic and Hormonal Health Panel for Women
The Women’s Core Heart & Metabolic Screening Panel is a comprehensive blood test panel designed to evaluate cardiovascular risk, metabolic health, thyroid function, inflammation, nutrient status, and iron stores in women. By combining advanced lipid testing, blood sugar markers, inflammatory indicators, and hormone-related biomarkers, this panel provides a broad, data-driven view of a woman’s cardiometabolic profile.
Heart disease remains a leading health concern for women, yet risk factors often present differently than in men. Subtle metabolic changes, insulin resistance, thyroid imbalance, chronic inflammation, and micronutrient deficiencies can all influence long-term cardiovascular and metabolic health. This panel integrates traditional and advanced biomarkers—including Lipoprotein (a), Apolipoprotein B, hs-CRP, Hemoglobin A1c, fasting insulin, thyroid markers, vitamin D, and ferritin—to support a deeper understanding of these interconnected systems.
Unlike single-marker tests, this women’s heart and metabolic screening panel examines multiple physiological pathways at once. It evaluates cholesterol transport particles, blood glucose regulation, systemic inflammation, liver and kidney function, red and white blood cell health, iron storage, and thyroid hormone activity. Together, these results provide a layered assessment of cardiovascular risk factors and metabolic performance.
This panel is appropriate for women seeking proactive health monitoring, baseline screening, or ongoing tracking of known cardiometabolic markers. It is particularly valuable during life stages associated with hormonal change—such as perimenopause and menopause—when shifts in lipid levels, insulin sensitivity, thyroid function, and inflammation may occur.
By offering a comprehensive, clinically relevant set of biomarkers in one panel, the Women’s Core Heart & Metabolic Screening Panel supports informed discussions between patients and healthcare providers about prevention, monitoring, and long-term cardiovascular wellness.
When and Why Someone Would Order This Panel
Proactive Cardiovascular Risk Assessment in Women
Many women choose a heart and metabolic screening panel as part of preventive health care. Even in the absence of symptoms, cardiovascular risk factors can develop gradually over time. Elevated Apolipoprotein B, increased Lipoprotein (a), subtle inflammation measured by hs-CRP, or early insulin resistance may not produce noticeable symptoms but can influence long-term heart health.
This panel may be considered by women who:
-
Have a family history of heart disease, high cholesterol, or diabetes
-
Want to assess baseline cardiovascular risk
-
Are experiencing metabolic changes during midlife
-
Have previously abnormal lipid or blood sugar results
-
Are monitoring thyroid function or nutrient status
Evaluation of Metabolic Health and Insulin Resistance
Insulin resistance often develops silently and may precede type 2 diabetes by years. By measuring fasting insulin and Hemoglobin A1c alongside a comprehensive metabolic panel, this screening helps evaluate how efficiently the body regulates blood glucose. Women with central weight changes, polycystic ovary syndrome (PCOS), metabolic syndrome risk factors, or a history of gestational diabetes may benefit from this broader metabolic evaluation.
Monitoring Hormonal and Thyroid-Related Changes
Thyroid function plays a central role in metabolism, lipid regulation, and energy levels. TSH and Free T4 testing can help identify patterns suggestive of hypothyroidism or hyperthyroidism. Because thyroid dysfunction can influence cholesterol levels and body weight, including thyroid markers in a cardiometabolic panel supports a more integrated assessment.
Nutrient and Iron Status Considerations
Vitamin D deficiency and low ferritin (iron stores) are common in women and may affect energy, immune function, and overall wellness. Assessing these markers alongside cardiovascular and metabolic biomarkers allows for a more complete health overview.
Overall, women may order this panel for preventive screening, ongoing monitoring, or to better understand how cardiovascular, metabolic, hormonal, and nutritional factors interact in their individual health profile.
What Does the Panel Measure?
Advanced Cardiovascular Markers
Lipid Panel
Measures total cholesterol, HDL cholesterol, LDL cholesterol (calculated), and triglycerides to evaluate traditional lipid-related cardiovascular risk.
Apolipoprotein B (ApoB)
Reflects the total number of atherogenic lipoprotein particles, including LDL particles. ApoB provides insight into particle burden beyond standard cholesterol values.
Lipoprotein (a) [Lp(a)]
A genetically influenced lipoprotein associated with increased cardiovascular risk in some individuals. Lp(a) levels are largely inherited and typically stable over time.
High-Sensitivity C-Reactive Protein (hs-CRP)
A marker of low-grade systemic inflammation that may be associated with cardiovascular risk.
Metabolic and Glycemic Markers
Hemoglobin A1c (HbA1c)
Reflects average blood glucose levels over approximately three months.
Insulin (Fasting)
Helps assess insulin production and may provide insight into insulin resistance when interpreted alongside glucose markers.
Comprehensive Metabolic Panel (CMP)
Evaluates glucose, electrolytes, liver enzymes, kidney function markers, and protein levels, offering a broad view of metabolic and organ health.
Thyroid Function Markers
Thyroid-Stimulating Hormone (TSH)
Signals how the thyroid gland is being regulated by the pituitary gland.
Free T4 (Thyroxine)
Measures circulating unbound thyroid hormone available for biological activity.
Hematologic and Nutrient Markers
Complete Blood Count (CBC) with Differential and Platelets
Assesses red blood cells, white blood cells, hemoglobin, hematocrit, and platelets—providing insight into anemia, immune status, and overall blood health.
Vitamin D, 25-Hydroxy (Total)
Evaluates vitamin D status, important for bone health, immune function, and metabolic processes.
Ferritin
Reflects iron storage levels in the body and may help identify iron deficiency or iron overload patterns.
Together, these biomarkers provide a comprehensive view of cardiovascular, metabolic, endocrine, inflammatory, and hematologic health.
How Patients and Healthcare Providers Use the Results
Identifying Cardiovascular Risk Patterns
Healthcare providers may use results from this panel to evaluate risk factors associated with atherosclerotic cardiovascular disease. Elevated ApoB, high LDL cholesterol, increased Lp(a), or elevated hs-CRP may indicate increased cardiovascular risk. These markers can help guide discussions around lifestyle strategies, monitoring frequency, and further evaluation when appropriate.
Assessing Metabolic Syndrome and Diabetes Risk
Patterns such as elevated triglycerides, reduced HDL cholesterol, increased fasting insulin, and higher Hemoglobin A1c levels may suggest insulin resistance or metabolic syndrome. Early identification allows for timely intervention and monitoring to reduce the likelihood of progression to type 2 diabetes.
Evaluating Thyroid-Related Metabolic Effects
Abnormal TSH and Free T4 results may indicate hypothyroidism or hyperthyroidism. Because thyroid dysfunction can affect cholesterol levels, weight regulation, and energy metabolism, identifying imbalances supports more accurate interpretation of lipid and metabolic findings.
Addressing Nutrient and Iron Imbalances
Low ferritin levels may suggest iron deficiency, which can contribute to fatigue and anemia. Vitamin D deficiency may influence bone health and immune function. Identifying these patterns allows healthcare providers to recommend appropriate follow-up testing or evidence-based management strategies.
Supporting Long-Term Monitoring
For women with known cardiometabolic risk factors, this panel can be used periodically to monitor trends over time. Tracking changes in lipid particles, inflammation markers, glucose regulation, thyroid function, and nutrient status supports a more personalized and proactive healthcare strategy.
A Comprehensive View of Women’s Cardiometabolic Health
The Women’s Core Heart & Metabolic Screening Panel brings together advanced cardiovascular biomarkers, metabolic indicators, thyroid hormones, inflammation markers, and nutrient assessments into one integrated evaluation. By examining how these systems interact, the panel provides meaningful insight into the complex factors that influence heart and metabolic health in women.
Rather than focusing on a single measurement, this panel offers a broad foundation for preventive screening and longitudinal monitoring. It supports informed, evidence-based conversations between patients and healthcare providers and encourages a proactive approach to cardiovascular and metabolic wellness.
Understanding heart health in women requires attention to lipid particles, inflammation, insulin sensitivity, thyroid balance, and nutritional status. This comprehensive screening panel helps illuminate those interconnected pathways—supporting clarity, awareness, and long-term health planning grounded in objective laboratory data.